According to our data, ectopic expression of the oncogenic miR-155 further supports CD34+ CML cells to evade the anti-proliferative effects of BMP and TGF-β1. This evidence concerns the gene TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive.